Company patents
Ypsomed AG
Ypsomed AG's patent strategy is heavily concentrated in Drug Delivery Devices, accounting for 94.5% of its portfolio, with a notable surge in 2024 (YoY +168.8%) followed by a decline in 2025 and so far in 2026, suggesting a potential shift in focus or a peak in innovation around 2024. Despite this concentration, the company also shows an emerging interest in Healthcare Informatics, which saw a significant 133.3% YoY growth in 2024, indicating a strategic move towards integrating digital health solutions with its core medical device offerings.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
110 US filings (since 2023) · 4 categories · 4 themes
Mechanical or electromechanical systems designed for precise, often self-administered, delivery of medicaments, including features for dose setting, needle insertion/retraction, and safety mechanisms to prevent premature activation.
Systems that integrate digital technology, sensors, or connectivity to monitor, track, or automate aspects of medication administration, often providing data feedback, personalized recommendations, or secure logging.
Systems and methods for non-invasive or minimally invasive collection and analysis of physiological data (e.g., blood pressure, electrolytes, genetic markers, B cell repertoire) to assess patient health status, screen for conditions, or aid in diagnosis.
Delivery systems specifically engineered to administer advanced drug formulations (e.g., microparticles, biologics, extended-release systems) to achieve precise targeting, controlled release kinetics, or enhanced therapeutic efficacy within the body.
Patents
Showing 1-10 of 168